• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Eli Lilly's mirikizumab improves fatigue in patients with Crohn's disease in...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 26, 2021 at 11:52: PM
via Eli Lilly reports data from Phase 2 SERENITY study evaluating mirikizumab compared to placebo in patients with moderately to severely active Crohn's disease (CD) at 12 weeks.

article source
 

<



Similar threads

cafead
FDA approves Eli Lilly&#039;s drug for eczema
Replies
0
Views
7
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly&#039;s weight loss drug tirzepatide gets approval in China
Replies
0
Views
31
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly&#039;s Alzheimer&#039;s Drug Obtains FDA Approval. Here&#039;s Why the Stock Isn&#039;t Taking Off.
Replies
0
Views
34
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly Alzheimer&#039;s drug approved by US FDA
Replies
0
Views
38
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Biden joins Sanders&#039; campaign targeting Novo Nordisk, Eli Lilly&#039;s diabetes and obesity drug prices
Replies
0
Views
41
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote